| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DHD10401B |
Research Grade Farletuzumab |
1.0 mg |
$1,380.00
|
 |
BUY
|
| DHB91702A |
Research Grade Fasinumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91702B |
Research Grade Fasinumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD30402B |
Research Grade Favezelimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD30402A |
Research Grade Favezelimab |
100 µg |
$420.00
|
|
BUY
|
| DHC88101A |
Research Grade Fazpilodemab |
100 µg |
$615.00
|
|
BUY
|
| DHC88101B |
Research Grade Fazpilodemab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHJ92102B |
Research Grade Feladilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92102A |
Research Grade Feladilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD80804A |
Research Grade Felzartamab |
100 ug |
$380.00
|
|
BUY
|
| DHD80804B |
Research Grade Felzartamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ53501A |
Research Grade Fezakinumab |
100 ug |
$428.00
|
|
BUY
|
| DHJ53501B |
Research Grade Fezakinumab |
1.0 mg |
$1,562.00
|
|
BUY
|
| DHD30405B |
Research Grade Fianlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD30405A |
Research Grade Fianlimab |
100 ug |
$380.00
|
|
BUY
|
| DHD03701B |
Research Grade Ficlatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD03701A |
Research Grade Ficlatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC09614B |
Research Grade Fidasimtamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHC09614A |
Research Grade Fidasimtamab |
100 ug |
$615.00
|
|
BUY
|
| DHC29905B |
Research Grade Figitumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC29905A |
Research Grade Figitumumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02223A |
Research Grade Finotonlimab |
100 ug |
$420.00
|
|
BUY
|
| DHH02223B |
Research Grade Finotonlimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD25201A |
Research Grade Flanvotumab |
100 ug |
$420.00
|
|
BUY
|
| DHD25201B |
Research Grade Flanvotumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ69101A |
Research Grade Fletikumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ69101B |
Research Grade Fletikumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD72504A |
Research Grade Flotetuzumab |
100 ug |
$615.00
|
|
BUY
|
| DHD72504B |
Research Grade Flotetuzumab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHB95402B |
Research Grade Fontolizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB95402A |
Research Grade Fontolizumab |
100 mg |
$380.00
|
|
BUY
|
| DHC27705A |
Research Grade Foralumab |
100 ug |
$430.00
|
|
BUY
|
| DHC27705B |
Research Grade Foralumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHB91601A |
Research Grade Fresolimumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91601B |
Research Grade Fresolimumab |
1.0 mg |
$1,378.00
|
|
BUY
|
| DHD85405A |
Research Grade Frexalimab |
100 µg |
$420.00
|
|
BUY
|
| DHD85405B |
Research Grade Frexalimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ24003B |
Research Grade Frovocimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ24003A |
Research Grade Frovocimab |
100 ug |
$380.00
|
|
BUY
|
| DHB91703A |
Research Grade Fulranumab |
100 ug |
$430.00
|
|
BUY
|
| DHB91703B |
Research Grade Fulranumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHJ32901A |
Research Grade Galegenimab |
100 ug |
$540.00
|
|
BUY
|
| DHJ32901B |
Research Grade Galegenimab |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHE03401A |
Research Grade Galiximab |
100 ug |
$380.00
|
|
BUY
|
| DHE03401B |
Research Grade Galiximab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09606A |
Research Grade Gancotamab |
100 ug |
$490.00
|
|
BUY
|
| DHC09606B |
Research Grade Gancotamab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DHC29902A |
Research Grade Ganitumab |
100 ug |
$380.00
|
|
BUY
|
| DHC29902B |
Research Grade Ganitumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12503B |
Research Grade Gantenerumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12503A |
Research Grade Gantenerumab |
100 ug |
$380.00
|
|
BUY
|
| DHB88201B |
Research Grade Garadacimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB88201A |
Research Grade Garadacimab |
100 ug |
$380.00
|
|
BUY
|
| DHC33101A |
Research Grade Garetosmab |
100 ug |
$420.00
|
|
BUY
|
| DHC33101B |
Research Grade Garetosmab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ70115A |
Research Grade Garivulimab |
100 ug |
$420.00
|
|
BUY
|
| DHJ70115B |
Research Grade Garivulimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD14201A |
Research Grade Gatipotuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14201B |
Research Grade Gatipotuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD95102A |
Research Grade Gatralimab |
100 ug |
$380.00
|
|
BUY
|
| DHD95102B |
Research Grade Gatralimab |
100 mg |
$1,380.00
|
|
BUY
|
| DHE14003B |
Research Grade Gavilimomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE14003A |
Research Grade Gavilimomab |
100 ug |
$380.00
|
|
BUY
|
| DHB90009A |
Research Grade Gefurulimab |
100 µg |
$615.00
|
|
BUY
|
| DHB90009B |
Research Grade Gefurulimab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHD37501A |
Research Grade Gemtuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHD37501B |
Research Grade Gemtuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH02224A |
Research Grade Geptanolimab |
100 ug |
$420.00
|
|
BUY
|
| DHH02224B |
Research Grade Geptanolimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHB95602A |
Research Grade Gevokizumab |
100 ug |
$420.00
|
|
BUY
|
| DHB95602B |
Research Grade Gevokizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD68904A |
Research Grade Giloralimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68904B |
Research Grade Giloralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC06704B |
Research Grade Gimsilumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC06704A |
Research Grade Gimsilumab |
100 ug |
$380.00
|
|
BUY
|
| DHA94801A |
Research Grade Ginisortamab |
100 ug |
$420.00
|
|
BUY
|
| DHA94801B |
Research Grade Ginisortamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH37201A |
Research Grade Girentuximab |
100 ug |
$430.00
|
|
BUY
|
| DHH37201B |
Research Grade Girentuximab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHG93101A |
Research Grade Glembatumumab |
100 ug |
$475.00
|
|
BUY
|
| DHG93101B |
Research Grade Glembatumumab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHJ60601A |
Research Grade Glenzocimab |
100 ug |
$540.00
|
|
BUY
|
| DHJ60601B |
Research Grade Glenzocimab |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHC90714A |
Research Grade Glofitamab |
100 ug |
$560.00
|
|
BUY
|
| DHC90714B |
Research Grade Glofitamab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHE58702B |
Research Grade GLP1-like peptide conjugated to Anti-Human GIPR (AMG 133) mAb |
|
$2,210.00
|
|
BUY
|
| DHE58702A |
Research Grade GLP1-like peptide conjugated to Anti-Human GIPR (AMG 133) mAb |
|
$615.00
|
|
BUY
|
| DHB94404B |
Research Grade Golimumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHB94404A |
Research Grade Golimumab |
100 ug |
$420.00
|
|
BUY
|
| DHF66401A |
Research Grade Golocdacimab |
100 µg |
$420.00
|
|
BUY
|
| DHF66401B |
Research Grade Golocdacimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC21302A |
Research Grade Gomiliximab |
100 ug |
$380.00
|
|
BUY
|
| DHC21302B |
Research Grade Gomiliximab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC82401B |
Research Grade Gosuranemab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC82401A |
Research Grade Gosuranemab |
100 ug |
$380.00
|
|
BUY
|
| DHF19802B |
Research Grade Gresonitamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHF19802A |
Research Grade Gresonitamab |
100 ug |
$615.00
|
|
BUY
|
| DHC41801A |
Research Grade Grisnilimab |
100 ug |
$420.00
|
|
BUY
|
| DHC41801B |
Research Grade Grisnilimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH28812A |
Research Grade Gumokimab |
100 ug |
$420.00
|
|
BUY
|
